ISRCTN61640561
Active, not recruiting
未知
This study aims to assess post-market safety and performance of stenfilcon A sphere & toric
CooperVision0 sites105 target enrollmentMarch 26, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Myopia, astigmatism, hyperopia
- Sponsor
- CooperVision
- Enrollment
- 105
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 8 to 75 years old (inclusive)
- •2\. Current wearer of the Stenfilcon A Sphere or Toric contact lens
Exclusion Criteria
- •1\. Participation in a contact lens or contact lens care product clinical trial within the previous 30 days
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Clinical study of a range of soft contact lens brandsMyopia, astigmatism, hyperopia, presbyopiaEye DiseasesISRCTN12617867CooperVision Inc Ltd700
Completed
Phase 4
Post market study to evaluate safety and effectiveness of the InnFocus MicroShunt® (MIDI Arrow) in patients with primary open angle glaucomaPrimary open-angle glaucoma10018307NL-OMON42294Innfocus Inc.25
Completed
Not Applicable
Post Market Study of the InnFocus MicroShuntPrimary Open Angle GlaucomaNCT02177123InnFocus Inc.107
Recruiting
Not Applicable
Prospective, Post-market Evaluation of Safety and Efficacy of a Local Osteo-Enhancement Procedure (LOEP) in the Proximal Femur of Women in Europe With Osteoporosisproximal femur with high risk for fragility fractureosteoporosisproximal femur bone mineral densityNL-OMON51693AgNovos Healthcare30
Completed
Not Applicable
Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety StudyInfluenzaNCT01037829Novartis Vaccines4,529